Business Lupin launches generic of Janssen Pharma’s VTE drug in U.S. October 1, 2025 gopalkumarthakur@gmail.com Rivaroxaban for Oral Suspension is indicated for treatment of venous thromboembolism (VTE) and reduction in the risk of recurrent VTE in paediatric patients Related posts: Decoding cryptos Urban Company’s ₹1,900 crore IPO to open on September 10; sets price band at ₹98-103 per share Automotive software in India seeing long development cycles as regulatory pressures adding to existing bottlenecks: BlackBerry firm Sahara firm seeks SC nod for sale of group’s assets to Adani properties
